Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Ketamine vs. Midazolam: Testing Rapid Relief of Suicide Risk in Depression


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01700829

Organisation Name: New York State Psychiatric Institute

Overal Status: Completed

Start Date: June 2012

Last Update: March 11, 2020

Lead Sponsor: New York State Psychiatric Institute

Brief Summary: This study is designed to compare the effectiveness of two medications, Ketamine and Midazolam, for rapidly relieving suicidal thoughts in people suffering from depression.

The first drug, Ketamine, is an experimental antidepressant that early studies have shown may quickly reduce suicidal thoughts, but we are not sure how well it may work. Midazolam, the comparison drug, is not thought to reduce depression or suicidal thoughts.

Conditions:
  • Major Depressive Disorder
  • Suicidal Ideation


Total execution time in seconds: 0.37701416015625